Targeting BCL-2 with the BH3 Mimetic ABT-199 in Estrogen Receptor-Positive Breast Cancer-Reference-Cited by-同舟云学术

Targeting BCL-2 with the BH3 Mimetic ABT-199 in Estrogen Receptor-Positive Breast Cancer

Published:2013-07 Issue:1 Volume:24 Page:120-129
ISSN:1535-6108
Container-title:Cancer Cell
language:en
Short-container-title:Cancer Cell

Author:

Vaillant François,Merino Delphine,Lee Lily,Breslin Kelsey,Pal Bhupinder,Ritchie Matthew E.,Smyth Gordon K.,Christie Michael,Phillipson Louisa J.,Burns Christopher J.,Mann G. Bruce,Visvader Jane E.,Lindeman Geoffrey J.

Publisher

Elsevier BV

Subject

Cancer Research,Cell Biology,Oncology

Reference39 articles.

1. Proposal for a modified grading system based on mitotic index and Bcl2 provides objective determination of clinical outcome for patients with breast cancer;Abdel-Fatah;J. Pathol.,2010

2. A Ki67/BCL2 index based on immunohistochemistry is highly prognostic in ER-positive breast cancer;Ali;J. Pathol.,2012

3. American Society of Clinical Oncology clinical practice guideline: update on adjuvant endocrine therapy for women with hormone receptor-positive breast cancer;Burstein;J. Clin. Oncol.,2010

4. Intrinsic molecular signature of breast cancer in a population-based cohort of 412 patients;Calza;Breast Cancer Res.,2006

5. Phosphatidylinositol 3-kinase/AKT-mediated activation of estrogen receptor alpha: a new model for anti-estrogen resistance;Campbell;J. Biol. Chem.,2001

Cited by 236 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cell Death: Mechanisms and Potential Targets in Breast Cancer Therapy;International Journal of Molecular Sciences;2024-09-07

2. Newer combination treatments for breast cancer coexisting with acute myeloid leukemia in the novel regimens era: A case report and literature review;Oncology Letters;2024-07-23

3. Therapy for Hormone Receptor-Positive, Human Epidermal Growth Receptor 2-Negative Metastatic Breast Cancer Following Treatment Progression via CDK4/6 Inhibitors: A Literature Review;Breast Cancer: Targets and Therapy;2024-04

4. Anticancer and anti-metastasis activity of 1,25 dihydroxycholecalciferols and genistein in MCF-7 and MDA-MB-231 breast cancer cell lines;Heliyon;2023-11

5. Small molecule inhibition of TFF3 overcomes tamoxifen resistance and enhances taxane efficacy in ER+ mammary carcinoma;Cancer Letters;2023-11